Gilmartin was clear that the trial should be halted and that the drug might have to be taken off the market.
Meanwhile, the European Medicines Agency in London announced it would review drugs similar to Vioxx.
Pfizer Inc. warned doctors on Friday that one of its bestselling painkillers, Bextra, might increase the risk of a heart attack or stroke in coronary artery bypass surgery patients.
